Company profile

Quantum Genomics is a biotechnology company that specializes in the research and development of drugs for the treatment of cardiovascular diseases such as high blood pressure and heart failure.

Source: Cofisem - Last Update: 30 Jun 2020
Key Executives
Chief Executive Officer Jean-Philippe Milon
Chief Financial Officer Benoît Gueugnon
Investor Relations Director Benoît Gueugnon
Director Research & Development Fabrice Balavoine
Source: Cofisem - Last Update: 15 Apr 2020
Key figures
Millenium 2019 2018 2017 2016 2015
Net sales 6
Consumed purchases 88 301 773 256 156
Payroll 2,776 2,403 2,456 1,823 1,600
Operating profit -10,760 -13,598 -10,292 -6,216 -4,310
Income tax 1,547 -1,458 -1,150 -958 714
Net income -9,078 -11,990 -9,381 -5,242 -3,764
Fiscal year end 12.19 12.18 12.17 12.16 12.15
Length of fiscal year (month) 12 12 12 12 12
Currency & Unit EUR - thousands EUR - thousands EUR - thousands EUR - thousands EUR - thousands
Account Standards
Source: Cofisem - Last Update: 30 Jun 2020
Shareholder information
Free float 84.36 %
Tethys 5.50 %
Lionel Segard 3.52 %
Managers 3.38 %
André Gombert 3.24 %
Source: Cofisem - Last Update: 15 Apr 2020

Financial analysis

Equity research report, in partnership with Morningstar

View Report

Address

Quantum Genomics

33 Rue Marbeuf
FR-75008 Paris
France
Source: Cofisem - Last Update: 30 Jun 2020

Contact

Marc Karako
Phone number: +33 (0)1 85 34 77 75
Source: Quantum Genomics - Last Update: 30 Jun 2020